MALDI-TOF-MS reveals differential N-linked plasma-and IgG-glycosylation profiles between mothers and their newborns

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Jansen, Bas C ^a   Bondt, Albert ^a,b   Reiding, Karli R ^a   Scherjon, Sicco A ^c   Vidarsson, Gestur ^d   Wuhrer, Manfred ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d SANQUIN RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988891186     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep34001     Document Type: Article

References (48)

1. Trowsdale, J. & Betz, A. G. Mother's little helpers: mechanisms of maternal-fetal tolerance. Nature Immunol. 7, 241-246 (2006).
2. Munoz-Suano, A., Hamilton, A. B. & Betz, A. G. Gimme shelter: the immune system during pregnancy. Immunol Rev 241, 20-38 (2011).
3. Larsson, A., Palm, M., Hansson, L.-O., Basu, S. & Axelsson, O. V. E. Reference values for 1-acid glycoprotein, 1-antitrypsin, albumin, haptoglobin, C-reactive protein, IgA, IgG and IgM during pregnancy. Acta Obstet. Gynecol. Scand. 87, 1084-1088 (2008).
4. Simister, N. E. Placental transport of immunoglobulin G. Vaccine 21, 3365-3369 (2003).
5. van Furth, R., Schuit, H. R. E. & Hijmans, W. The immunological Development of The Human Fetus. J. Exp. Med. 122, 1173-1188 (1965).
6. Hytten, F. Blood volume changes in normal pregnancy. Clin Haematol 14, 601-612 (1985).
7. Schwab, I. & Nimmerjahn, F. Intravenous immunoglobulin therapy: how does IgG modulate the immune system Nat. Rev. Immunol. 13, 176-189 (2013).
8. Shields, R. L. et al. Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human Fc RIII and Antibodydependent Cellular Toxicity. J. Biol. Chem. 277, 26733-26740 (2002).
9. Thomann, M. et al. In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity. Plos One 10, e0134949 (2015).
10. Story, C. M., Mikulska, J. E. & Simister, N. E. A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus. J. Exp. Med. 180, 2377-2381 (1994).
11. Roopenian, D. C. & Akilesh, S. FcRn: the neonatal Fc receptor comes of age. Nat. Rev. Immunol. 7, 715-725 (2007).
12. Williams, P. J. et al. Selective placental transport of maternal IgG to the fetus. Placenta 16, 749-756 (1995).
13. Kibe, T. et al. Glycosylation and Placental Transport of Immunoglobulin G. J. Clin. Biochem. Nutr. 21, 57-63 (1996).
14. Einarsdottir, H. K. et al. Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G. Glycoconj J 30, 147-157 (2013).
15. Dashivets, T. et al. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants. Plos One 10, e0143520 (2015).
16. Jefferis, R. Isotype and glycoform selection for antibody therapeutics. Arch. Biochem. Biophys. 526, 159-166 (2012).
17. Shields, R. L. et al. High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R. J Biol Chem 276, 6591-6604 (2001).
18. Kaneko, Y., Nimmerjahn, F. & Ravetch, J. V. Science 313, 670 (2006).
19. Bakchoul, T. et al. Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia. Blood 122, 321-327 (2013).
20. Huffman, J. E. et al. Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adults. Hum. Mol. Genet. 20, 5000-5011 (2011).
21. Jansen, B. C. et al. Pregnancy-associated serum N-glycome changes studied by high-throughput MALDI-TOF-MS. Nature Scientific Reports 6, 23296 (2016).
22. Reiding, K. R., Blank, D., Kuijper, D. M., Deelder, A. M. & Wuhrer, M. High-throughput profiling of protein N-glycosylation by MALDI-TOF-MS employing linkage-specific sialic acid esterification. Anal. Chem. 86, 5784-5793 (2014).
23. Jansen, B. C. et al. MassyTools: A high throughput targeted data processing tool for relative quantitation and quality control developed for glycomic and glycoproteomic MALDI-MS. J. Proteome Res. 14, 5088-5098 (2015).
24. Clerc, F., Reiding, K. R., Jansen, B. C., Bondt, A. & Kammeijer, G. S. M. Human plasma protein N-glycosylation. Glycoconjugate J. 33, 309-343 (2015).
25. Stapleton, N. M., Einarsdottir, H. K., Stemerding, A. M. & Vidarsson, G. The multiple facets of FcRn in immunity. Immunol Rev 268, 253-268 (2015).
26. Kapur, R. et al. A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. Blood 123, 471-480 (2014).
27. de Haan, N., Reiding, K. R., Driessen, G., van der Burg, M. & Wuhrer, M. Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early Childhood. J Proteome Res (2016).
28. Malek, A., Sager, R., Kuhn, P., Nicolaides, K. H. & Schneider, H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am. J. Reprod. Immunol. 36, 248-255 (1996).
29. Holland, M. et al. Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCAassociated systemic vasculitis. Biochim. Biophys. Acta 1760, 669-677 (2006).
30. Yang, W. H. et al. An intrinsic mechanism of secreted protein aging and turnover. Proc. Natl. Acad. Sci. USA 112, 13657-13662 (2015).
31. Vahlquist, A., Rask, L., Peterson, P. A. & Berg, T. The Concentrations of Retinol-Binding Protein, Prealbumin, and Transferrin in the Sera of Newly Delivered Mothers and Children of Various Ages. Scand. J. Clin. Lab. Inv. 35, 569-575 (1975).
32. Fryer, A. A., Jones, P., Strange, R., Hume, R. & Bell, J. E. Plasma protein levels in normal human fetuses: 13 to 41 weeks' gestation. Br. J. Obstet. Gynaecol. 100, 850-855 (1993).
33. Crandall, B. F. & Lau, H. L. Alpha-fetoprotein: a review. CRC Cr. Rev. Cl. Lab. Sc. 15, 127-185 (1981).
34. Malek, A., Sager, R., Lang, A. B. & Schneider, H. Protein transport across the in vitro perfused human placenta. Am. J. Reprod. Immunol. 38, 263-271 (1997).
35. Gitlin, J. D. & Gitlin, D. Protein binding by specific receptors on human placenta, murine placenta, and suckling murine intestine in relation to protein transport across these tissues. J Clin Invest 54, 1155-1166 (1974).
36. Ben-Hur, H. et al. Transport of maternal immunoglobulins through the human placental barrier in normal pregnancy and during inflammation. Int. J. Mol. Med 16, 401-407 (2005).
37. Ashwell, a. G. & Harford, J. Carbohydrate-Specific Receptors of the Liver. Ann. Rev. Biochem. 51, 531-554 (1982).
38. Steirer, L. M., Park, E. I., Townsend, R. R. & Baenziger, J. U. The Asialoglycoprotein Receptor Regulates Levels of Plasma Glycoproteins Terminating with Sialic Acid 2,6-Galactose. The Journal of Biological Chemistry 284, 3777-3783 (2009).
39. Park, E. I., Mi, Y., Unverzagt, C., Gabius, H.-J. & Baenziger, J. U. The asialoglycoprotein receptor clears glycoconjugates terminating with sialic acid 2,6GalNAc. Proc. Natl. Acad. Sci. USA 102, 17125-17129 (2005).
40. Pineda-Martinez, S. et al. Immunoglobulin Concentrations in Plasma and Saliva During the Neonatal Period. Pediatrics & Neonatology 57, 213-218 (2016).
41. Morell, A., Skvaril, F., van Loghem, E. & Kleemola, M. Human IgG subclasses in maternal and fetal serum. Vox Sang 21, 481-492 (1971).
42. Bladergroen, M. R. et al. Automation of High-Throughput Mass Spectrometry-Based Plasma N-Glycome Analysis with Linkage-Specific Sialic Acid Esterification. J. Proteome Res. 14, 4080-4086 (2015).
43. Bondt, A. et al. IgG Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancyassociated changes. Mol. Cell. Proteomics 13, 3029-3039 (2014).
44. Wilcoxon, F. Individual Comparisons by Ranking Methods. Biometics Bull. 1, 80-83 (1945).
45. Dunn, O. J. Multiple Comparisons among Means. J. Am. Stat. Assoc. 56, 52-64 (1961).
46. Ceroni, A. et al. GlycoWorkbench: A Tool for the Computer-Assisted Annotation of Mass Spectra of Glycans. J. Proteome Res. 7, 1650-1659 (2008).
47. Pucic, M. et al. High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol. Cell. Proteomics 10, M111.010090 (2011).
48. Saldova, R. et al. Association of N-Glycosylation with Breast Carcinoma and Systemic Features Using High-Resolution Quantitative UPLC. J. Proteome Res. 13, 2314-2327 (2014).